TY - JOUR
T1 - Predicting the oral uptake efficiency of chemicals in mammals
T2 - Combining the hydrophilic and lipophilic range
AU - O'Connor, Isabel A.
AU - Huijbregts, Mark A.J.
AU - Ragas, Ad M.J.
AU - Hendriks, A. Jan
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Environmental risk assessment requires models for estimating the bioaccumulation of untested compounds. So far, bioaccumulation models have focused on lipophilic compounds, and only a few have included hydrophilic compounds. Our aim was to extend an existing bioaccumulation model to estimate the oral uptake efficiency of pollutants in mammals for compounds over a wide Kow range with an emphasis on hydrophilic compounds, i.e. compounds in the lower Kow range. Usually, most models use octanol as a single surrogate for the membrane and thus neglect the bilayer structure of the membrane. However, compounds with polar groups can have different affinities for the different membrane regions. Therefore, an existing bioaccumulation model was extended by dividing the diffusion resistance through the membrane into an outer and inner membrane resistance, where the solvents octanol and heptane were used as surrogates for these membrane regions, respectively. The model was calibrated with uptake efficiencies of environmental pollutants measured in different mammals during feeding studies combined with human oral uptake efficiencies of pharmaceuticals. The new model estimated the uptake efficiency of neutral (RMSE=14.6) and dissociating (RMSE=19.5) compounds with logKow ranging from -10 to +8. The inclusion of the Khw improved uptake estimation for 33% of the hydrophilic compounds (logKow<0) (r2=0.51, RMSE=22.8) compared with the model based on Kow only (r2=0.05, RMSE=34.9), while hydrophobic compounds (logKow>0) were estimated equally by both model versions with RMSE=15.2 (Kow&Khw) and RMSE=15.7 (Kow only). The model can be used to estimate the oral uptake efficiency for both hydrophilic and hydrophobic compounds.
AB - Environmental risk assessment requires models for estimating the bioaccumulation of untested compounds. So far, bioaccumulation models have focused on lipophilic compounds, and only a few have included hydrophilic compounds. Our aim was to extend an existing bioaccumulation model to estimate the oral uptake efficiency of pollutants in mammals for compounds over a wide Kow range with an emphasis on hydrophilic compounds, i.e. compounds in the lower Kow range. Usually, most models use octanol as a single surrogate for the membrane and thus neglect the bilayer structure of the membrane. However, compounds with polar groups can have different affinities for the different membrane regions. Therefore, an existing bioaccumulation model was extended by dividing the diffusion resistance through the membrane into an outer and inner membrane resistance, where the solvents octanol and heptane were used as surrogates for these membrane regions, respectively. The model was calibrated with uptake efficiencies of environmental pollutants measured in different mammals during feeding studies combined with human oral uptake efficiencies of pharmaceuticals. The new model estimated the uptake efficiency of neutral (RMSE=14.6) and dissociating (RMSE=19.5) compounds with logKow ranging from -10 to +8. The inclusion of the Khw improved uptake estimation for 33% of the hydrophilic compounds (logKow<0) (r2=0.51, RMSE=22.8) compared with the model based on Kow only (r2=0.05, RMSE=34.9), while hydrophobic compounds (logKow>0) were estimated equally by both model versions with RMSE=15.2 (Kow&Khw) and RMSE=15.7 (Kow only). The model can be used to estimate the oral uptake efficiency for both hydrophilic and hydrophobic compounds.
KW - Bioaccumulation
KW - Hydrogen bond donor
KW - Hydrophilic
KW - Mammals
KW - Mechanistic model
KW - Oral uptake efficiency
UR - http://www.scopus.com/inward/record.url?scp=84870300890&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2012.10.015
DO - 10.1016/j.taap.2012.10.015
M3 - Article
C2 - 23147570
AN - SCOPUS:84870300890
SN - 0041-008X
VL - 266
SP - 150
EP - 156
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 1
ER -